32 Recruiting Squamous Cell Carcinoma of Head and Neck Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Squamous Cell Carcinoma of Head and Neck
Top Recruiting Squamous Cell Carcinoma of Head and Neck Studies
Pembrolizumab Plus Olaparib in LA-HNSCC
📍 Indiana University Simon Comprehensive Cancer Center — Indianapolis, Indiana
View Study & Checklist ➔TBio-4101 and Pembro wi/ or w/o Chemo in Recurrent/Metastatic HNSCC
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔HYPORT: A Phase I/II Study of Hypofractionated Post-operative Radiation Therapy for Head and Neck Cancer
📍 University of Texas Southwestern Medical Center — Dallas, Texas
View Study & Checklist ➔MicroRNA Markers in Head and Neck Cancers
📍 University of Colorado Cancer Center — Aurora, Colorado
View Study & Checklist ➔A Clinical Trial Evaluating TG4050 in Head and Neck Cancer
📍 Mayo Clinic Jacksonville — Jacksonville, Florida
View Study & Checklist ➔A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
📍 University of California at San Diego Moores Cancer Center — La Jolla, California
View Study & Checklist ➔Neoadjuvant CADI-05 in Combination With Pembrolizumab for Surgically Resectable Locally Advanced Head and Neck Squamous Cell Carcinomas
📍 Fox Chase Cancer Center — Philadelphia, Pennsylvania
View Study & Checklist ➔5-Azacytidine and/or Nivolumab in Resectable HPV-Associated HNSCC
📍 Yale University — New Haven, Connecticut
View Study & Checklist ➔A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence
📍 Highlands Oncology Group, PA — Fayetteville, Arkansas
View Study & Checklist ➔A Study of Head and Neck MRI and Tumor Microenvironment Biomarkers
📍 Princess Margaret Cancer Center — Toronto, Ontario
View Study & Checklist ➔A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
📍 Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
View Study & Checklist ➔A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
📍 Ironwood Cancer and Research Center — Chandler, Arizona
View Study & Checklist ➔Measurable Residual Disease Detection Using Tumor-Informed ctDNA Surveillance After Curative-Intent Treatment in HPV-Independent Squamous Cell Carcinoma of the Head and Neck
📍 Massachusetts Eye and Ear — Boston, Massachusetts
View Study & Checklist ➔5-Fluorouracil Response and Optimization STudy (The FROST Trial)
📍 Washington University School of Medicine — St Louis, Missouri
View Study & Checklist ➔HN-BIO 02: A Phase II Randomized Study of the Effects of Delayed Elective Radiotherapy on Head and Neck MRI and Immune Response Biomarkers
📍 Princess Margaret Cancer Centre — Toronto, Ontario
View Study & Checklist ➔Tumor-Informed ctDNA Testing for MRD Following Treatment of Squamous Cell Carcinoma
📍 University of California, San Francisco — San Francisco, California
View Study & Checklist ➔